InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: None

Monday, 03/20/2017 1:55:46 AM

Monday, March 20, 2017 1:55:46 AM

Post# of 2099
I missed this interesting tidbit from the recent write up.... Very interesting.

https://www.baystreet.ca/articles/research_reports/lifesci/VBLT011917.pdf

"We hosted a key opinion leader (KOL) event at the Society for Immunotherapy of Cancer (SITC) meeting in November 2016 with Dr. Hideho Okada, the director of the Brain Tumor Immunotherapy Center at the University of California San Francisco. At the event, Dr. Okada expressed his view that VB-111 is one of the more exciting treatments in development for GBM."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News